Bio-Techne (MEX:TECH) Construction In Progress: MXN358 Mil (As of Mar. 2026)


MEX:TECH Bio-Techne Corp MEX:TECH
83 GF Score
Price MXN1,090.00
GF Value MXN1,117.60
! 8 Warning Signs
View Full Analysis

What is Bio-Techne Construction In Progress?

Bio-Techne MEX:TECH 83 Construction In Progress is MXN358 Mil as of Mar. 2026. GuruFocus rates MEX:TECH with a GF Score™ of 83/100 and a GF Value™ of MXN1,117.60. The stock has 8 warning signs investors should review.

Bio-Techne's quarterly construction in progress declined from Sep. 2025 (MXN372 Mil) to Dec. 2025 (MXN349 Mil) but then increased from Dec. 2025 (MXN349 Mil) to Mar. 2026 (MXN358 Mil).

Bio-Techne's annual construction in progress increased from Jun. 2023 (MXN266 Mil) to Jun. 2024 (MXN728 Mil) but then declined from Jun. 2024 (MXN728 Mil) to Jun. 2025 (MXN441 Mil).

Bio-Techne Construction In Progress Historical Data

* Premium members only.

The historical data trend for Bio-Techne's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Techne Construction In Progress Chart

Bio-Techne Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 976.85 437.14 265.58 728.21 440.98

Bio-Techne Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 650.96 440.98 371.60 348.86 357.72
MEX:TECH
83GF Score
Bio-Techne Corp MEX:TECH
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio-Techne Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of MXN358 Mil mean?
Bio-Techne (MEX:TECH) has a Construction In Progress of MXN358 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Bio-Techne and its competitors.
Is Bio-Techne's Construction In Progress too high?
Bio-Techne's current Construction In Progress is MXN358 Mil. Overall, Bio-Techne has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Bio-Techne's Construction In Progress compare to HALO and IBRX?
Bio-Techne's Construction In Progress of MXN358 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Biotechnology company?
A good Construction In Progress depends on the Biotechnology industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Bio-Techne and its competitors. Bio-Techne's current Construction In Progress is MXN358 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Techne stock overvalued right now?
Bio-Techne (MEX:TECH) has a current Construction In Progress of MXN358 Mil. The stock's GF Value™ is MXN1,117.60, compared to a current price of MXN1,090.00 — trading 2.5% below its estimated fair value. The current Construction In Progress is MXN358 Mil. Bio-Techne's overall GF Score™ is 83/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Bio-Techne (MEX:TECH), the current Construction In Progress is MXN358 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bio-Techne (MEX:TECH) Overvalued in 2026?

Based on GuruFocus' analysis, Bio-Techne stock appears to be undervalued. The current stock price of MXN1,090.00 is trading 2.5% below its estimated GF Value™ of MXN1,117.60.

Key valuation signals for MEX:TECH:

  • Construction In Progress: MXN358 Mil
  • GF Value™: MXN1,117.60 vs. price of MXN1,090.00 (2.5% below fair value)
  • GF Score™: 83/100 with 8 warning signs

No single metric tells the full story. See the MEX:TECH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bio-Techne Business Description

Address 614 McKinley Place N.E., Minneapolis, MN, USA, 55413
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
83GF Score

Get the complete analysis for MEX:TECH

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,090.00
Price
MXN1,117.60
GF Value